ArticleBMJ open gastroenterology2018

Putative biomarkers of vedolizumab resistance and underlying inflammatory pathways involved in IBD.

Christoffer Soendergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.